Total Funding
61
Total FundingSeries D raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
485195
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products.
Acquired by 
GlaxoSmithKline
About the Company
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products. It is engaged in the sale and marketing of these products.
Its product portfolio includes Axid, a nizatidin; InnoPran XL and DynaCirc CR for the treatment of hypertension; Omacor to reduce high triglycerides; and Rythmol SR.
It provides products for the treatment of
elevated cholesterol and triglycerides, acid reflux disease, and prevention of coronary complications in patients with coronary heart disease.
It distributes its products to physicians engaged in primary care, cardiovascular, and specialized medical areas.
Reliant Pharmaceuticals was established in 1999, headquartered in Liberty Corner, New Jersey.
